11: Managing Nutrition Side Effects Flashcards

1
Q

CTCAE (Severity) Grades and Description:
Anorexia and Early Satiety

A

1 - loss of appetite without changing eating habits
2 - oral intake altered without significant wt loss or malnutrition; oral supplements started
3 - associated with significant wt loss or malnutrition; EN/PN indicated
4 - life-threatening consequences, urgent intervention indicated
5 - death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Considerations for:
Anorexia and Early Satiety

A

evaluate:
conditions that impact digestion
meds that may be causing digestion/GI issues (pain meds, antacids, H2-receptor antagonists, PPI, antiemetics, etc)
pt’s use of recommended symptom management strategies and meds - figure out any impediments to adherence
assess food/fluid intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Nutrition and Behavior Interventions for:
Anorexia and Early Satiety

A

small/frequent meals of HCHP foods
set a schedule
maximize intake at time of day appetite is best
oral supplements
consume liquids separate from meals
use foods that are easy to prepare/serve
keep convenience foods (frozen meals, bars, supplements) on hand
approach eating as part of treatment
engage in light activity to help move food through the GI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pharmacotherapy for:
Anorexia and Early Satiety

A

Antihistamines - Periactin in children
steroids
progestational agents (provera, megace)
prokinetic agents (reglan)
cannabinoids (marinol, syndros, cesamet)
antidepressants (Remeron–off label use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CTCAE (Severity) Grades and Description:
Taste & Smell Changes

A

1 - altered taste, no change in diet
2 - altered taste with change – noxious or unpleasant taste; loss of taste

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Considerations for:
Taste & Smell Changes

A

assess etiology of the changes – chemo changes my be transient during treatment cycle; radiation may be processive and more permanent
evaluate for candidiasis
encourage good oral hygiene
assess food/fluid intake
investigate foods that illicit the sense of dysgeusia or ageusia
ID which flavors the patient does perceive as accurate/pleasant/tolerate and modify intake using this profiles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nutrition and Behavior Interventions for:
Taste & Smell Changes

A

Little/Off Taste: use fruity/salty, +marinades, herbs/spices/lemon/etc, remind hot foods (spicy) is not a flavor but a sensation so likely not to help

Bitter/acidic/metallic Taste: sweet foods with meals, sweet/sour beverages, strongly flavored spices like onion/garlic, sugar-free lemon drops/gums/mints to improve mouth taste, alternative protein like chicken/eggs/tofu, use bamboo/plastic silverware or chopsticks to reduce metal taste

Salty Taste: naturally sweet foods, boiled foods reduce flavor, low-sodium products

Sweet Taste: bland/sour flavors, dilute juices, choose veggies over fruit

Smell issues: cold/room temp foods, avoid strong odor foods (fish, cabbage), avoid cooking areas during meal prep, avoid lengthy cooking processes (crockpot), vent cooking areas

Extra tips: small/frequent meals, oral supplements, cup with a lid an straw for cold/room temp to reduce exposure to flavor/odors, approach as part of treatment, educate patient about time frame of changes and recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pharmacotherapy for:
Taste & Smell Changes

A

cleansing rinse: 3/4 tsp salt, 1 tsp baking soda, 4 c water. rinse mouth with 1 c of mixture 3-4 times/day

“miracle fruit” might help
Herbal Tea (gymnema sylvestra) consumed before meals, may inhibit sweet taste
zinc supplements have NOT been proven to help with loss for ENT patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CTCAE (Severity) Grades and Description:
Constipation

A

1 - occasional/intermittent symptoms, occasional use of softeners/laxatives/diet mods/enema

2 - persistent symptoms with regular use of laxatives/enemas, limiting ADLs

3 - Obstipation with manual evacuation indicated, limited self-care ADLs

4 - life-threatening consequences, urgent intervention indicated

5 - death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Considerations for:
Constipation

A

evaluate:
bowel habits/pattern and changes with treatment
frequency of bowel movements and volume/character of stool
use of meds that may slow gastric emptying and influence GI function
patient’s use of recommended meds and bowel regimen for symptom management, explore with the patient any impediments to adherence

assess food/fluid intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nutrition and Behavior Interventions for:
Constipation

A

Aim for min 64-80 oz
Add +32 oz fluid if using medicinal fibers
adequate fiber intake overall — increase to goal
daily routine that includes a hot beverage/hot cereal/or high-fiber food to stimulate bowels
add food-related probiotics or other supplements to help
engage in light activity
hen on opioids — combination of stimulant laxative plus a stool softener is well tolerated
schedule adequate bathroom time and privacy
report if there hasn’t been a movement for more than 3 days

educate on:
importance of adequate hydration, fiber intake and total food intake
effect of each med on bowel function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pharmacotherapy for:
Constipation

A

Insoluble fiber
Medicinal fiber – metamucil/benefiber
stool softener – colace/surfak
lubricants – mineral oil
osmotic laxatives – miralax/MoM
stimulant laxative agents – dulcolax/senokot/ex-lax
opioid antagonist – relistor/symproic
herbals – probiotics, slippery elm, aloe juice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CTCAE (Severity) Grades and Description:
Diarrhea

A

1 - increase of less than 4 stools/day over baseline, mild increase in ostomy output compared to baseline

2 - increase to 4-6 stools/day over baseline; moderate increase in ostomy output compared to baseline, limiting instrumental activities ADLs

3 - increase to 7+ stools/day, hospitalization indicated; severe increase in ostomy; limited self-care ADL

4 - life-threatening consequences, urgent intervention indicated

5 - death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Considerations for:
Diarrhea

A

Assess etiology — osmotic, malabsorptive, secretory, infectious, chemo, radiation enteritis, GI mucositis, GVHD, pancreatic insufficiency

Evaluate pattern and changes with treatment, frequency/volume/consistency

Assess for risk factors of dumping syndrome, lactose intolerance, fat malabsorption

Review meds that could be impacting GI function

Review pt’s use of recommended bowel regimen for symptom management & meds, work to resolve impediments of adherence

Food/fluid intake review

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nutrition and Behavior Interventions for:
Diarrhea

A

small/frequent meals
adequate hydration
low fat, low-insoluble-fiber, or low lactose—or any combo as needed
increase soluble fiber foods
if gas/bloated, limited gas-forming foods
eliminate caffeine/alcohol/highly spiced foods
avoid sorbitol and other sugar-alcohol containing products

educate patient on electrolyte-containing foods/fluids, use of oral rehydration salts/products/recipes if needed, use of lactase enzyme products and subs if needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pharmacotherapy for:
Diarrhea

A

Opioid receptor agonist–loperamide/imodium or lomotil
Hormonal-octreotide/sandostatin
opioids-paregoric
anti-inflammatory/anti-diarheal–peptobismol or kaopectate
bile acid sequestrant–cholestyramine/questran
anticholinergics–diphenhydramine/benadryl
medicinal fibers–metamucil, konsyl, citrucel
preventive for gut radiotherapy-ethyol
amino acids- L-glutamine (may reduce duration), Enterade
Probiotics (maybe, with caution)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

CTCAE (Severity) Grades and Description:
Dysphagia

A

1 - symptomatic, able to eat regular diet

2 - symptomatic and altered eating or swallowing

3 - severely altered eating or swallowing; tube feeding, PN or hospitalization indicated

4 - life-threatening consequences, urgent intervention indicated

5 - death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Considerations for:
Dysphagia

A

assess etiology of it
review swallow study and SLP recs
assess food/fluid intake

19
Q

Nutrition and Behavior Interventions for:
Dysphagia

A

alter food textures as per SLP
thickeners as needed per SLP
moist foods of similar texture to help with cohesive bolus in mouth
avoid dry foods and foods that separate into pieces (rice/crackers)
moisten dry foods with gravies/sauces
alternate solid food and liquids
eat/drink in upright position
avoid distractions and limit talking while eating
avoid straws unless recommended by SLP
for Odynophagia–use pain meds or topical anesthetics/strays/lozenges
Practice chin-tuck swallowing and double swallowing to help food clear the pharynx
practice verbalization after swallowing liquids to help clear the pharynx

educate patient on:
strategies to address QOL concerns – thickened water
strategies to address impediments to adherence
which medications need to be taken with cohesive foods or in liquid form
dysphagia guidelines as per IDDSI
use of slurry textures

20
Q

Pharmacotherapy for:
Dysphagia

A

Topical anesthetics–lidocaine spray/Xylocaine
Analgesia–opioids
Thickeners–simply thick gel, thicken right, thicken up, thick & easy, thick it

21
Q

CTCAE (Severity) Grades and Description:
Fatigue

A

1 - fatigue relieved by rest

2 - fatigue not relieved by rest; limited instrumental activities of ADLs

3 - fatigue no relieved by rest; limiting self-care ACL

22
Q

Considerations for:
Fatigue

A

evaluate for anemia, hydration status, unintentional wt loss and sarcopenia
consider appropriateness of MVI or mineral supplement
assess actual food/fluid intake

23
Q

Nutrition and Behavior Interventions for:
Fatigue

A

small/frequent meals and snacks
consider taking oral supplements to promote adequate energy intake
keep nonperishable snacks at bedside
plan a larger meal for when the appetite is best
consume soft, easy to chew foods if eating is difficult
consider frozen meals, meal boxes, or grocery pick up services
use easy-to-prepare meals, snacks, prepared foods
save energy by limiting “duties or chores” as much as possible
continue to preform ADL and light activities
monitor wt weekly, report wt loss, and monitor hydration
consider PT consult for muscle strengthening
avoid excessive daytime sleep to help improve nighttime sleep quality

24
Q

Pharmacotherapy for:
Fatigue

A

blood transfusions
erythropoietin given as epoetin alfa (epogen, procrit)

25
Q

CTCAE (Severity) Grades and Description:
Malabsorption

A

2 - altered diet, oral intervention indicated

3 - inability to aliment adequatley, PN indicated

4 - life-threatening consequences, urgent intervention indicated

5 - death

(1 not listed)

26
Q

Considerations for:
Malabsorption

A

evaluate pattern of bowel habits and changes associated with surgery, diagnosis and treatment

evaluate frequency of stooling/volume/color/consistency/possible EPI

check fecal elastase

Evaluate patients ability to manage the bowel regimen and use of enzymes–note the timing of the enzymes use vs food/beverage intake. Titrate up the dose until efficacy is achieved, allow 1-2 weeks for each change in dosage. work with patient to limit impediments of adherence

some enzymes need a PPI concurrently to maintain effectiveness

Pt shouldn’t sprinkle or mix contents of enzyme capsules on dairy products or consume foods with ph >4. should be mixed well with foods, tell patients to sprinkle them on applesauce immediately before eating a meal

assess for lactose intolerance

review food/fluid intake

27
Q

Nutrition and Behavior Interventions for:
Malabsorption

A

for bloating/gas: avoid straws/swallowing air/carbonated beverages/chewing gum; chew slowly/thoroughly with mouth closed

for bloating/cramping/gas from milk products: low lactose diet, use of lactase-treated dairy or lactase pills/drops

for gas from veggies: avoid cruciferous veggies, beans/legumes, or take enzyme supplement with a-galactosidase and invertase (beano)

for bulky/foul smelling stools/fatty stools: take enzymes before first bite and if taking more than one pill, take second halfway through; recommend medium-chain triglycerides to augment calorie intake if needed; educate patient on fat malasorption and using fat-gram counters or mobile nutrition apps to help track intake and assess enzyme adequacy; educate patient on which foods/beverages don’t need enzymes; educate on appropriate dosage

28
Q

Pharmacotherapy for:
Malabsorption

A

Gas-X, Lactaid, Beano
Probiotics, with caution

Enzymes:
Dosing per fat-gram content—
500-1000 lipase units per g of fat
do NOT exceed 4000 lipase units per g of fat
do NOT exceed 2500 lipase units per kg of body weight/meal or 10,000 units per kg of body weight/day

Dosing per meal/snack—
20,000-75,000 lipase units per meal, 5000-50,000 lipase units per snack

Dosing per kg of body weight—
500 lipase units/kg for meals, increasing as tolerated
250 lipase units/kg for snacks, increasing as tolerated

29
Q

CTCAE (Severity) Grades and Description:
Nausea/Vomiting

A

Nausea:
1 - loss of appetite without alterations in eating habits
2 - oral intake decreased without significant wt loss, dehydration or malnutrition
3 - inadequate oral energy or fluid intake; tube feeding, PN or hospitalization indicated

Vomiting:
1 - intervention not indicated
2 - outpatient IV fluids, medical intervention indicated
3 - tube feeding, PN or hospitalization indicated
4 - life-threatening consequences
5 - death

30
Q

Considerations for:
Nausea/Vomiting

A

access etiology of N/V— anticipatory, acute (24 after chemo), delayed (1-7 days after chemo), breakthrough (occurs despite prophylactic meds, requiring “rescue” meds), refractory (all meds have failed)

eval pt’s ability to manage meds, work to address impediments of adherence

assess for presence of constipation

for radiotherapy-only treatment–assess the site or radiation/field size/total dose. high risk treatments are total body, upper abd, and craniospinal

for chemo, with or without RT, assess the emetogenic potential of the chemo agent

evaluate the timing and patterns of N/V associated with the treatment cycle, medication use, and food/beverage intake

assess food/fluid intake

31
Q

Pharmacotherapy:
Nausea/Vomiting

A

Acute - serotonin antagonists (5-HT3 receptor antagonists — ondansetron/zofran, dolasetron/anzemet, granisetron/kytril, palonosetron/aloxi, tropisetron/navoban

Delayed–dopamine antagonists, particularly phenothiazines — prochlorperazine/compazine, promethazine/phenergan

Delayed–Neurokinin-1 (NK-1) receptor antagonists – aprepitant or fosaperpitant/Emend, netupitant and palonsetron/akynezo, rolapitant/varubi

Benzamindes: methoclopramide/reglan

cannabinoids: dronabinol/marinol, liquefied dronabinol/syndros, nabilone/cesamet

Benzodiazapines: lorazepam/ativan, diazepam/valium — anticipatory

Corticosteroids: dexamethasone/decadron, prednisone

Combo meds for CINV prophlaxis: a steriod + 5-HT3 + NK-1 with or without benzamide — decadron+Zofran+Emend plus possibly reglan

Investigational complementary therapies: ginger tea, ginger ale, 0.5-1 ginger extract, acupressure bracelets, acupuncture, massage, transcutaneous electrical nerve stimulation, relaxation techniques, and self-hypnosis

32
Q

Nutrition and Behavior Interventions for:
Nausea/Vomiting

A

small/frequent meals
bland/starchy foods and clear liquids–room temp
avoid greasy, high-fat foods and highly seasoned foods
consume liquids between meals
limit exposure to cooking odors by avoiding food prep areas and use exhaust fans or open windows
avoid/limit strong-smelling lotions, soaps, perfumes, and air fresheners
rest with head elevated for 30 minutes after eating
time meals for when nausea meds are working their best
take pain meds with crackers or light foods

33
Q

CTCAE (Severity) Grades and Description:
Oral Mucositis and Esophagitis

A

Mucositis:
1 - asymptomatic or mild symptoms; intervention not indicated
2 - moderate pain/ulcer that doesn’t interfere with oral intake, modified diet indicated
3 - severe pain; interfering with oral intake
4 - life-threatening consequences; urgent intervention needed
5 - death

Esophagitis:
1 - asymptomatic or mild symptoms; intervention not indicated
2 - symptomatic, altered eating or swallowing, oral supplements indicated
3 - severely altered eating or swallowing, tube feeding/PN/hospitalization indicated
4 - life-threatening consequences; urgent intervention needed
5 - death

34
Q

Nutrition and Behavior Interventions for:
Oral Mucositis and Esophagitis

A

Cryotherapy during admin of 5-FU bolus and high-dose melphalan chemo. Have patients consume ice chips, ice water or frozen ice pop for 30 minutes to reduce possible development of mucositis

choose foods lower in acidity
avoid strong seasoning/spices
moisten dry foods with sauces/gravies
choose soft foods
serve foods at cool/room temperature
prepare smoothies with low acid fruits, such as melons, bananas, peaches and add yogurt/milk/tofu
limit carbonated beverages
avoid alcohol-containing mouthwashes

35
Q

Considerations for:
Oral Mucositis and Esophagitis

A

assess etiology of mucositis and esophagitis: HSCT, chemo, biotherapy, radiation, GVHD

evaluate for oral infections

evaluate patient’s ability to adopt recommended symptom management strategies and meds; work to address impediments to adherence

encourage good oral care using soft toothbrush or toothette and woven dental floss

advise the patient to keep dentures clean and limit their use if increasing irritation

advise avoiding alcohol ingestion and tobacco use

recommend lip balm to moisten lips

assess food/fluid intake

36
Q

Pharmacotherapy:
Oral Mucositis and Esophagitis

A

amino acids: L-glutamine (may reduce mucositis)

Topical anesthetics: gels/rinses containing lidocaine, codeine, or morphine

Analgesia: opioids, anti-inflammatory agents

topical anti-inflammatory gels: gels with dexamethasone

Mucosal barriers and protectants: zinc gluconate and taurine (Gel-X); adherent gel (Gelclair)

Soothing Rinse: 3/4 tsp salt, 1 tsp baking soda, 4 cups water. Rinse/gargle with 1 cup of mixture 3-4 times/day

anti-infective prophylaxis: rinse, swish, and spit with topical analgesic, anti-inflammatory, and coating agent (viscous lidocaine, diphenhydramine, aluminum hydroxide and magnesium hydroxide suspension—-aka Magic Mouth Wash) 3-4 times/day

Mucositis may require antiviral prophylaxis medications

37
Q

CTCAE (Severity) Grades and Description:
Oral Candidiasis

A

1 - asymptomatic, local symptomatic management

2 - oral intervention indicated (antifungal)

3 - IV antifungal intervention indicated

38
Q

Considerations for:
Oral Candidiasis

A

assess etiology: onc treatments may reduce blood counts, making patients susceptible to infections; note the timing of infection within treatment cycle, transplant and so on

39
Q

Nutrition and Behavior Interventions for:
Oral Candidiasis

A

practice effective oral hygiene, using saltwater rinses, and avoid mouthwashes that contain alcohol

replace/sanitize toothbrushes, oral appliances, and dentures

choose soft textured foods, low acid foods and beverages, and avoid carbonation

consume active-culture yogurt several times daily

40
Q

Pharmacotherapy for:
Oral Candidiasis

A

polyene antifungal: nystatin/mucostatin

Azole antifungal: fluconazole/diflucan

gemicidal mouthwash: chlorhexidine gluconate/peridex

probiotics: use with caution

salt cleansing rinse

41
Q

CTCAE (Severity) Grades and Description:
Xerostomia

A

1 - symptomatic (dry/thick saliva) without significant dietary alteration; unstimulated saliva flow >0.2 ml/min

2 - Moderate symptoms; oral intake alternations (copious water, other lubricants, diet limited to purees and/or soft/moist foods); unstimulated saliva flow 0.1-0.2 ml/min

3 - inability to adequately aliment orally; tube feeding or PN indicated; unstimulated saliva <0.1 ml/min

42
Q

Considerations for:
Xerostomia

A

assess etiology: chemo-induced might be transient; radiation-induced changes to the oral cavity typically occur in the 2nd week of radiation and may be permanent. Encourage good oral hygiene

43
Q

Nutrition and Behavior Interventions for:
Xerostomia

A

small/frequent meals
alternate bites/sips at meals
add broth/gravies/sauces to meals and moisten dry foods in liquids
sip liquids throughout the day; aim for 8-10 c of fluid daily; carry a water bottle
swish and spit with club soda or carbonated water
use a humidifier at home to moisten the air
practice good oral hygiene
suck on hard candy, frozen grapes or melon balls
avoid mouthwash that contains alcohol
avoid alcoholic drinks and tobacco products

44
Q

Pharmacotherapy for:
Xerostomia

A

Mouth conditioners/artificial salivias: biotene, BioXtra, Caphosol, Glandosane, Salivart; Xero-Lube, MouthKote, Xyliments

Prophylaxis therapy: amifostine (Ethyol); Pilocarpine (Salagen)

Salt cleansing rinse